Organovo inks L’Oreal deal for 3d-printed skin
FDA withdraws older guidance documents
The FDA is withdrawing 47 draft guidance documents published before the end of 2013 that it never finalized or acted on.
Agency officials posted the announcement in the Federal Register, explaining that the move is designed to boost efficiency and transparency regarding its development of guidance documents.
Sorin hopes Perceval valve will rescue flat results
Diabetes: J&J plans mobile app trial for OneTouch Verio Flex device
Medtronic launches new spine devices
Oculus Rift heads to the neurosurgery suite
Ohio medtech company Surgical Theater is partnering with UCLA neurosurgeons to incorporate virtual reality video game technology into 1 of its surgical visualization systems.
Axonics generates another $17m
Axonics Modulation Technologies said it raised nearly $17.3 million in an equity financing as it develops next-generation neuromodulation technology to treat various medical conditions.
The California company disclosed the funding in a recent regulatory filing that does not name specific investors.
TAVI: U.K. study finds 60% survival rate at 3 years
The survival rate for high-risk patients with transcatheter aortic valve implants surpassed 61% at 3 years and drops to 45.5% at 5 years, according to a new analysis of data from the U.K. Transcatheter Aortic Valve Implantation Registry.
Profound Medical goes public in reverse merger
Profound Medical yesterday said it’s slated to hit the public markets in Canada after a reverse merger, also revealing a $24 million private placement to fuel clinical trial work.
Hologic raises outlook again after Street-beating Q2
Study: Low-battery defib revisions costly
